Sorry, meant to say not soon enough but soon, wrote too fast. I am ok to wait through Sep for P3 results, which is the main announcement we all want and need to see. I know nothing more than others here, just believe based on all that is known about the products and the company execs and the pharma space, that this company is doing all it can and has the product and determination to beg, borrow and steal its way to the finish line, which I think based on this financing, is close. I think having to wait for the P3 results is the worst cast that could have occurred over the last year. I believe something potentially good occurred to cause the screening halt. It may or may not have panned out as it potentially could. I believe the worst case is the P3 data comes out soon, and, I believe it will be a good, possibly negotiated sub-group result. Covering occurring at this low price makes sense to me, buying more at this price is bold, but, if one believes in the science, a few more shares at this low price helps the conscience.
News 
Market Data 
Discover 
